FOX40 News

Koya Medical Presents Two Newly Published Clinical Studies for Dayspring® Active Compression Treatments for Lymphedema and Venous Disease at the AVLS 2022 Annual Congress

OAKLAND, Calif., Oct. 24, 2022 /PRNewswire/ -- Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric ...
Business Wire

Koya Medical Presents Positive Interim Data from Randomized Trial Comparing its Dayspring Lymphedema Treatment to Pneumatic Compression

Interim clinical trial data presented at American Vein and Lymphatic Society Annual Congress demonstrate patient preference, strong therapy adherence, improved quality-of-life measures, and reduction ...
Business Wire

Koya Medical Secures First Reimbursement Codes for Dayspring, for Lymphedema; Publishes Clinical Data Demonstrating Improved Function, Appearance, Mood and Symptoms

OAKLAND, Calif.--(BUSINESS WIRE)--Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, announced today that its wearable, active ...
ksn.com

Koya Medical Announces Topline Results from Its Latest Trial on the Treatment of Lower Extremity Lymphedema at VENOUS2024

OAKLAND, Calif. and TAMPA, Fla., March 6, 2024 /PRNewswire/ -- Koya Medical, today announces topline results from its TEAYS trial. TEAYS (NCT05507346) is a prospective multi-center, randomized ...
vator

Koya Medical raises $26M for its wearable lymphedema therapeutic

You may not have heard of lymphedema, but there’s a decent chance you know someone who has it: an estimated 20 million Americans live with the disease, which is chronic, progressive, and incurable ...